1. Home
  2. EVLV vs ELVN Comparison

EVLV vs ELVN Comparison

Compare EVLV & ELVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Evolv Technologies Holdings Inc.

EVLV

Evolv Technologies Holdings Inc.

HOLD

Current Price

$6.74

Market Cap

988.3M

Sector

Technology

ML Signal

HOLD

Logo Enliven Therapeutics Inc.

ELVN

Enliven Therapeutics Inc.

HOLD

Current Price

$21.84

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EVLV
ELVN
Founded
2013
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Computer peripheral equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
988.3M
1.1B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
EVLV
ELVN
Price
$6.74
$21.84
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
5
Target Price
$9.13
$41.20
AVG Volume (30 Days)
3.2M
511.8K
Earning Date
11-13-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$136,501,000.00
N/A
Revenue This Year
$41.14
N/A
Revenue Next Year
$14.60
N/A
P/E Ratio
N/A
N/A
Revenue Growth
43.16
N/A
52 Week Low
$2.64
$13.30
52 Week High
$8.91
$25.96

Technical Indicators

Market Signals
Indicator
EVLV
ELVN
Relative Strength Index (RSI) 50.79 55.58
Support Level $6.10 $19.58
Resistance Level $6.85 $22.14
Average True Range (ATR) 0.27 1.13
MACD 0.13 0.03
Stochastic Oscillator 89.34 62.48

Price Performance

Historical Comparison
EVLV
ELVN

About EVLV Evolv Technologies Holdings Inc.

Evolv Technologies Holdings Inc offers an AI-based touchless security screening. Its touchless security screening systems use artificial intelligence software, cloud services, and sensors to reliably detect dangerous weapons while ignoring harmless items like cell phones, laptops, and keys. It offers products for purchase under a multi-year security-as-a-service subscription pricing model that delivers ongoing value to customers, generates predictable revenue, and creates expansion and upsell opportunities. The firm operates in a single segment that develops, manufactures, markets, and sells security screening products and specific services. Its products are used in different industries such as casinos, industrial workplaces, schools, and ticketed venues.

About ELVN Enliven Therapeutics Inc.

Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its product candidates include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.

Share on Social Networks: